Literature DB >> 16730149

Morphine and 6-acetylmorphine concentrations in blood, brain, spinal cord, bone marrow and bone after lethal acute or chronic diacetylmorphine administration to mice.

Emmanuelle Guillot1, Philippe de Mazancourt, Michel Durigon, Jean-Claude Alvarez.   

Abstract

The aim of this study was to evaluate postmortem incorporation of opiates in bone and bone marrow after diacetylmorphine (heroin) administration to mice. Mice were given acute (lethal dose of 300 mg/kg) or chronic (10 and 20 mg/kg/24 h for 20 days) intraperitoneal administration of diacetylmorphine. The two metabolites of diacetylmorphine, 6-acetylmorphine (6-AM) and morphine, were extracted from whole blood, brain, spinal cord, bone marrow and bone (after hydrolysis) using a liquid/liquid method. Quantification was performed by gas chromatography-mass spectrometry (GC/MS). Results showed that after acute administration, opiates were present in all studied tissues. Morphine concentrations appeared to be higher than those of 6-AM in blood (52.4 microg/mL versus 27.7 microg/mL, n=12), bone marrow (87.8 ng/mg versus 8.9 ng/mg, n=6) and bone (0.85 ng/mg versus 0.43 ng/mg, n=6), but 6-AM concentrations were higher than those of morphine in brain (14.0 ng/mg versus 7.4 ng/mg, n=12) and spinal cord (27.8 ng/mg versus 20.8 ng/mg, n=12). No correlation was found for both compounds between blood concentrations and either brain, spinal cord, bone or bone marrow concentrations while a significant one was found between brain and spinal cord concentrations either for morphine (r=0.89, n=12, p<0.001) or 6-AM (r=0.93, n=12, p<0.001), the concentration being higher in spinal cord than in brain. When bones were stored for 2 months, only 6-AM remained in bone marrow but not in bone. After chronic administration, mice being sacrificed by cervical dislocation 24 h after the last injection, no opiate was detected in any studied tissues. Further studies are required, in particular in human bones, but these results seem to show that 6-AM could be detect in bone marrow several weeks after the death and could be an alternative tissue for forensic toxicologist to detect a fatal diacetylmorphine overdose, even if no correlation between blood and bone marrow was observed. On the other hand, neither bone tissue nor bone marrow will allow the confirmation of a chronic diacetylmorphine use.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16730149     DOI: 10.1016/j.forsciint.2006.03.029

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  4 in total

Review 1.  State-of-the-art of bone marrow analysis in forensic toxicology: a review.

Authors:  Nathalie Cartiser; Fabien Bévalot; Laurent Fanton; Yvan Gaillard; Jérôme Guitton
Journal:  Int J Legal Med       Date:  2011-03       Impact factor: 2.686

2.  Detecting drugs in dry bone: a pilot study of skeletal remains with a post-mortem interval over 23 years.

Authors:  Gaia Giordano; Lucie Biehler-Gomez; Pierfausto Seneci; Cristina Cattaneo; Domenico Di Candia
Journal:  Int J Legal Med       Date:  2021-01-02       Impact factor: 2.686

3.  Morphine Accumulates in the Retina Following Chronic Systemic Administration.

Authors:  Nikolas Bergum; Casey-Tyler Berezin; Gregory Dooley; Jozsef Vigh
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-25

4.  Effects of maternal consumption of morphine on rat skeletal system development.

Authors:  Maryam Saeidinezhad; Vahid Razban; Hosein Safizadeh; Massood Ezzatabadipour
Journal:  BMC Musculoskelet Disord       Date:  2021-05-13       Impact factor: 2.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.